A. Nagel

Targeting Lewis Y (Ley) in Small Cell Lung Cancer with a Humanized Monoclonal Antibody, hu3S193: A Pilot Trial Testing Two Dose Levels

M. Kris, A. Scott, L. Krug, 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Improved tumor imaging and therapy via i.v. IgG-mediated time-sequential modulation of neonatal Fc receptor.

S. Larson, D. Scheinberg, J. Carrasquillo, 2007, The Journal of clinical investigation.

Targeting Lewis Y (LeY) in small cell lung cancer (SCLC) with a humanized monoclonal antibody, hu3S193.

L. Krug, A. Jungbluth, E. Quaia, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial.

J. Humm, S. Larson, M. Gönen, 2007, The Lancet. Oncology.

The value of gamma camera and computed tomography data set coregistration to assess Lewis Y antigen targeting in small cell lung cancer by (111)Indium-labeled humanized monoclonal antibody 3S193.

J. Humm, V. Reuter, L. Krug, 2008, European journal of radiology.